Literature DB >> 18789672

Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose.

Jocelyn Dudley1, Samarjit Das, Subhendu Mukherjee, Dipak K Das.   

Abstract

Recent studies have demonstrated the cardioprotective abilities of resveratrol, a polyphenolic antioxidant present in red wine. Resveratrol can also kill cancer cells at relatively higher doses by exerting a death signal. We reasoned that resveratrol might possess the ability to protect the cells at lower doses as observed during pharmacological preconditioning of the heart, while at higher doses cause cell death as found for cancer cells. To test this hypothesis, rats were randomly fed for 14 days by gavaging any of the four doses of resveratrol - 2.5, 5.0, 25 or 50 mg/kg - while vehicle-fed animals served as placebo control. After 14 days, isolated working hearts were prepared from both experimental and control animals, and the hearts were subjected to 30-min global ischemia followed by 2 h of reperfusion. The rats fed either 2.5 or 5 mg/kg dose of resveratrol for 14 days provided cardioprotection as evidenced by improved post-ischemic ventricular recovery and reduction of myocardial infarct size and cardiomyocyte apoptosis compared to control. In contrast, the hearts fed either 25 or 50 mg/kg dose of resveratrol depressed cardiac function and increased myocardial infarct size and number of apoptotic cells. The results for Western blots and RT-PCR demonstrated an increase of protein and RNA transcripts of redox proteins including thioredoxin (Trx)-1, Trx-2, glutaredoxin (Grx)-1, Grx-2, redox factor Ref-1 as well as redox-sensitive transcription factor NFkappaB, and survival factors such as phosphorylated-Akt (p-Akt), and Bcl-2 in the animals fed lower doses (2.5 and 5 mg/kg) of resveratrol, while the reverse was true for the animals fed higher doses (25 and 50 mg/kg) of resveratrol. The results thus indicate that at lower doses (2.5 or 5 mg/kg), resveratrol exerts survival signal by up-regulating anti-apoptotic and redox proteins Akt and Bcl-2, while at higher doses (>25 mg/kg), it potentiates a death signal by down-regulating redox proteins and up-regulating pro-apoptotic proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789672     DOI: 10.1016/j.jnutbio.2008.05.003

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  41 in total

Review 1.  APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.

Authors:  Mark R Kelley; Millie M Georgiadis; Melissa L Fishel
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

2.  Functional analysis of novel analogues of E3330 that block the redox signaling activity of the multifunctional AP endonuclease/redox signaling enzyme APE1/Ref-1.

Authors:  Mark R Kelley; Meihua Luo; April Reed; Dian Su; Sarah Delaplane; Richard F Borch; Rodney L Nyland; Michael L Gross; Millie M Georgiadis
Journal:  Antioxid Redox Signal       Date:  2011-01-04       Impact factor: 8.401

3.  Challenges of translating basic research into therapeutics: resveratrol as an example.

Authors:  James M Smoliga; Ole Vang; Joseph A Baur
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-11       Impact factor: 6.053

4.  Longevity nutrients resveratrol, wines and grapes.

Authors:  Istvan Lekli; Diptarka Ray; Dipak K Das
Journal:  Genes Nutr       Date:  2009-09-04       Impact factor: 5.523

5.  Characterization and modulation of human mesenchymal stem cell stress pathway response following hypothermic storage.

Authors:  William L Corwin; John M Baust; John G Baust; Robert G Van Buskirk
Journal:  Cryobiology       Date:  2014-02-06       Impact factor: 2.487

6.  Implications of differential stress response activation following non-frozen hepatocellular storage.

Authors:  William L Corwin; John M Baust; John G Baust; Robert G Van Buskirk
Journal:  Biopreserv Biobank       Date:  2013-02       Impact factor: 2.300

7.  Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway.

Authors:  Narasimman Gurusamy; Istvan Lekli; Subhendu Mukherjee; Diptarka Ray; Md Kaimul Ahsan; Mihaela Gherghiceanu; Lawrence M Popescu; Dipak K Das
Journal:  Cardiovasc Res       Date:  2009-12-03       Impact factor: 10.787

Review 8.  Resveratrol and cardiovascular system-the unfulfilled hopes.

Authors:  Małgorzata Chudzińska; Daniel Rogowicz; Łukasz Wołowiec; Joanna Banach; Sławomir Sielski; Robert Bujak; Anna Sinkiewicz; Grzegorz Grześk
Journal:  Ir J Med Sci       Date:  2020-11-21       Impact factor: 1.568

Review 9.  The biological responses to resveratrol and other polyphenols from alcoholic beverages.

Authors:  Lindsay Brown; Paul A Kroon; Dipak K Das; Samarjit Das; Arpad Tosaki; Vincent Chan; Manfred V Singer; Peter Feick
Journal:  Alcohol Clin Exp Res       Date:  2009-06-10       Impact factor: 3.455

Review 10.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.